Literature DB >> 16418424

Inhaled treprostinil [corrected] for treatment of chronic pulmonary arterial hypertension.

Robert Voswinckel, Hossein A Ghofrani, Friedrich Grimminger, Werner Seeger, Horst Olschewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16418424     DOI： 10.7326/0003-4819-144-2-200601170-00026

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  [Therapy of pulmonary arterial hypertension].

Authors:  R Voswinckel; F Reichenberger; H Gall; W Seeger; F Grimminger; H A Ghofrani
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

2.  Prostacyclin for pulmonary arterial hypertension.

Authors:  Hayley Barnes; Hui-Ling Yeoh; Toby Fothergill; Andrew Burns; Marc Humbert; Trevor Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-05-01

Review 3.  Prostacyclin for pulmonary hypertension in adults.

Authors:  N S Paramothayan; T J Lasserson; A U Wells; E H Walters
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 4.  Inhaled treprostinil and pulmonary arterial hypertension.

Authors:  Samuel T Nadler; Jeffrey D Edelman
Journal:  Vasc Health Risk Manag       Date:  2010-12-03

5.  Diagnosis and management of pulmonary arterial hypertension.

Authors:  Jeanne Houtchens; Douglas Martin; James R Klinger
Journal:  Pulm Med       Date:  2011-09-20

Review 6.  Inhaled treprostinil: a therapeutic review.

Authors:  Richard N Channick; Robert Voswinckel; Lewis J Rubin
Journal:  Drug Des Devel Ther       Date:  2012-01-24       Impact factor: 4.162

Review 7.  Prostanoid therapies in the management of pulmonary arterial hypertension.

Authors:  Barbara L LeVarge
Journal:  Ther Clin Risk Manag       Date:  2015-03-31       Impact factor: 2.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.